MMAE peptide,
monomethyl auristatin E,
monomethylauristatin E,
Monomethyl auristatin E,
474645-27-7,
UNII-V7I58RC5EJ,
MMAE,
Monomethylauristatin E,
V7I58RC5EJ,
N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide,
Monomethyl auristatin E (MMAE),
4Q5,
monomethyl-auristatin-e-mmae,
MMAE, monomethyl auristatin E,
SCHEMBL5402144,
CHEMBL2103835,
AOB5196,
DASWEROEPLKSEI-UIJRFTGLSA-N,
C39H67N5O7,
MFCD22124498,
s7721,
ZINC85537145,
CS-0837,
HY-15162,
AB0087989,
Y1831,
W-5883,
L-Valinamide, N-methyl-L-valyl-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-hydroxy-1- methyl-2-phenylethyl)amino)-1-methoxy-2-methyl-3-oxopropyl)-1-pyrrolidinyl)-2- methoxy-1-((1S)-1-methylpropyl)-4-oxobutyl)-N-methyl-,
N(sup 2)-(N-Methyl-L-valyl)-N(sup 1)-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-hydroxy-1-methyl-2- phenylethyl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-2-methoxy-1-((1S)- 1-methylpropyl)-4-oxobutyl)-N(sup 1)-methyl-L-valinamide,
VEDOTIN,
Vedotin [USAN],
Anti-CD79b-vc-vedotin,
Anti-CD79b-vc-MMAE,
Anti-CD79b-MC-MMAF,
Anti-CD79b-MCC-DM1,
D0M7EP,
CD79-targeted immunotoxins,
UNII-Q3606FDE0B,
CID11542188,
CID 11542188,
A12954,
CD79-targeted immunotoxins (non-Hodgkin's lymphoma),
CD79-targeted immunotoxins (non-Hodgkin's lymphoma), Genentech,
(S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1R,2R)-1-Hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxohe,
Anti-CD79 antibody-drug conjugates (non-Hodgkin's lymphoma), Genentech,